ADHD Trial, Recruiting NCT04279158 Sponsor: Hospices Civils de Lyon Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT04279158
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are male or female, aged between 18 and 75 years old (children aged 8–17 may also be eligible for the ADHD group specifically)
  • You have normal vision, or your vision is corrected (for example, with glasses or contact lenses)
  • You are covered by social security
  • You are willing and able to sign a written consent form agre- If you are a minor, your legal guardian(s) must also give written consent

For people who have had a stroke and have a condition called hemispatial neglect (difficulty noticing things on one side):

  • You had a stroke more than 1 month ago, with evidence of brain injury shown on a brain scan and by noticeable symptoms
  • Your condition has been confirmed as hemispatial neglect and not a different vision problem (confirm with trial site)

For people who have had a stroke and have a condition called optic ataxia (difficulty reaching or pointing accurately):

  • You had a stroke more than 1 month ago, with brain injury limited to a specific area called the parietal cortex, confirmed by an MRI scan
  • You experience difficulties pointing or reaching accurately, either with your hand or toward objects on a specific side

For people with ADHD (Attention Deficit Hyperactivity Disorder):

  • You have a formal ADHD diagnosis (either the inattentive type or the hyperactive/impulsive type) given by a neuropsychologist
  • You do not have any learning disabilities alongside your ADHD

For healthy volunteers:

  • You have no known neurological injury or condition

Who may not be able to join:

  • You have difficulties that would prevent you from following the study requirements, such as neurological, psychiatric, sensory, or movement-related problems
  • You are an adult who is under any form of legal protection (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Laure PISELLA, Centre de recherche de Neurosciences de Lyon (CRNL)

Phone: 4 72 91 34 05

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
26 November 2022
Est. completion
26 November 2031

Where this trial is recruiting

🇫🇷 France

Primary endpoints

error rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov